Heterozygous Atypical Cholinesterase: Management During ECT.
A 70-year old woman developed prolonged apnea during an initial administration of electroconvulsive therapy (ECT) with succinylcholine. Because of the duration of apnea, she was suspected of having a heterozygous type of atypical cholinesterase. Subsequent therapies were administered with a reduced dose of succinylcholine. Prolonged apnea did not recur.